비교리스트

 카트 문의
시장보고서
상품코드
1559556

세계의 폐암 수술 시장

Lung Cancer Surgery
발행일: | 리서치사: Global Industry Analysts, Inc. | 페이지 정보: 영문 279 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

폐암 수술 세계 시장은 2030년까지 83억 달러에 달할 것으로 예상됩니다

2023년 62억 달러로 추정되는 폐암 수술 세계 시장은 2023-2030년의 분석 기간 동안 연평균 4.2% 성장하여 2030년에는 83억 달러에 달할 것으로 예상됩니다. 이 보고서에서 분석한 부문 중 하나인 흉강경 수술은 CAGR 4.1%를 기록하여 분석 기간이 끝날 때까지 58억 달러에 도달할 것으로 예상됩니다. 최소 침습 수술 부문의 성장률은 분석 기간 동안 CAGR 4.6%로 추정됩니다.

미국 시장은 17억 달러로 추정, 중국은 CAGR 6.5%로 성장 전망

미국의 폐암 수술 시장은 2023년 17억 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2030년까지 18억 달러 규모에 도달할 것으로 예상되며, 2023-2030년의 분석 기간 동안 6.5%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 2.7%와 3.2%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다. 유럽에서는 독일이 연평균 3.3%의 성장률을 보일 것으로 예상됩니다.

세계 폐암 수술 시장 - 주요 동향 및 촉진요인 정리

폐암 수술이 오늘날 암 치료에서 중요한 요소인 이유는 무엇일까?

폐암은 여전히 세계에서 가장 널리 퍼져 있고 치명적인 암 중 하나이며, 수술과 같은 효과적인 치료법이 이 질병과의 싸움에서 매우 중요한 역할을 하고 있습니다. 폐암 수술은 종양과 암세포가 퍼져 있을 수 있는 주변 폐 조직을 제거합니다. 이 방법은 일반적으로 종양이 국한되어 있고 수술이 가능한 폐암, 특히 비소세포폐암(NSCLC)의 초기 단계에서 가장 효과적입니다. 비디오 보조 흉부 수술(VATS)이나 로봇 보조 수술과 같은 최소 침습 수술 등 수술 기법의 발전으로 환자 예후가 크게 개선되고 있습니다. 이러한 수술은 기존의 개흉 수술에 비해 수술 외상 및 회복 시간을 줄이고 합병증 위험을 줄이며 수술 후 삶의 질을 향상시킬 수 있습니다. 발견 방법이 개선되고 더 많은 폐암이 수술 가능한 단계에서 진단됨에 따라 치료 요법에서 수술의 역할은 계속 확대되고 있습니다.

기술의 발전은 폐암 수술을 어떻게 변화시키고 있는가?

폐암 수술을 둘러싼 환경은 보다 정확하고 덜 침습적인 수술을 가능하게 하는 기술의 발전으로 완전히 바뀌었습니다. 로봇 수술과 같은 기술 혁신은 외과 의사에게 높은 손재주와 통제력을 제공하여 건강한 조직을 보존하면서 복잡한 해부를 수행하고 종양을 정확하게 제거할 수 있게 해줍니다. 또한 실시간 CT 스캔 및 형광 영상진단과 같은 수술 중 영상진단 기술은 종양의 위치와 절제 단면의 평가 정확도를 향상시켜 첫 번째 수술에서 더 많은 암 조직을 확실하게 제거할 수 있게 했습니다. 이러한 발전은 외과적 개입의 성공률을 높일 뿐만 아니라 환자에게 미치는 신체적 영향을 최소화하고 회복 시간을 단축하고 수술 후 불편함을 줄일 수 있습니다.

조기 발견과 맞춤형 치료는 폐암 수술 결과에 어떤 영향을 미칠까?

조기 발견과 맞춤 치료 접근법은 폐암 수술 결과에 큰 영향을 미치고 있습니다. 고위험군에 대한 저선량 CT 검사의 개발로 폐암을 조기에 진단할 수 있게 되었으며, 수술적 절제가 가능하고 완치 가능성이 높은 단계에서 진단되는 경우가 많아졌습니다. 또한 종양의 유전적 프로파일링을 통해 종양의 특성을 파악하는 맞춤의료는 어떤 환자가 수술에 적합한지, 화학요법이나 표적치료와 같은 추가 치료에 어떻게 반응할지를 결정하는 데 있어 비약적인 발전을 이루었습니다. 이러한 맞춤형 접근법은 수술의 효과를 극대화하고 불필요한 치료를 최소화하는 치료 계획을 수립하는 데 도움이 됩니다.

폐암 수술 시장의 성장은 여러 가지 요인으로 인해 발생한다

폐암 수술 시장의 성장은 기술 발전, 발견 방법의 개선, 개인 맞춤형 의료에 대한 관심 증가 등 여러 가지 요인에 의해 주도되고 있습니다. 최소침습 수술 및 로봇 보조 수술과 같은 수술 기법의 혁신은 수술이 가능한 환자의 범위를 넓히고 환자 예후를 개선하여 많은 환자들에게 수술이 더 현실적인 선택이 될 수 있도록 했습니다. 또한, 검진 프로그램의 강화는 수술적 개입이 가장 효과적인 조기 암의 발견을 늘리는 데 중요한 역할을 하고 있습니다. 또한, 폐암의 유전적 기반에 대한 이해도가 높아짐에 따라 개인화된 수술적 치료가 보편화되어 보다 표적화되고 효과적인 개입이 가능해졌습니다. 이러한 발전은 폐암의 위험과 예방에 대한 인식이 높아지면서 폐암 치료에서 수술적 솔루션에 대한 수요를 지속적으로 견인하고 있으며, 이는 역동적이고 진화하는 시장을 반영하고 있습니다.

조사 대상 기업 예시(총 111개 주목)

  • Abbott Molecular, Inc.
  • AbbVie, Inc.
  • Accuray, Inc.
  • Ackermann Instrumente GmbH
  • AngioDynamics, Inc.
  • Baxter International, Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Daiichi Sankyo Co.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 24.09.27

Global Lung Cancer Surgery Market to Reach US$8.3 Billion by 2030

The global market for Lung Cancer Surgery estimated at US$6.2 Billion in the year 2023, is expected to reach US$8.3 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. Thoracotomy Procedure, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$5.8 Billion by the end of the analysis period. Growth in the Minimally Invasive Surgery segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.7 Billion While China is Forecast to Grow at 6.5% CAGR

The Lung Cancer Surgery market in the U.S. is estimated at US$1.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 6.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Lung Cancer Surgery Market - Key Trends & Drivers Summarized

Why Is Lung Cancer Surgery a Critical Component of Cancer Treatment Today?

Lung cancer remains one of the most prevalent and deadly cancers worldwide, making effective treatment modalities like surgery crucial in the fight against this disease. Surgery for lung cancer involves the removal of the tumor and surrounding lung tissue where cancer cells may have spread. This approach is generally most effective in the early stages of lung cancer, specifically non-small cell lung cancer (NSCLC), where the tumor is localized and operable. Advances in surgical techniques, including minimally invasive procedures such as video-assisted thoracic surgery (VATS) and robot-assisted surgery, have significantly improved outcomes for patients. These techniques reduce surgical trauma and recovery time, decrease the risk of complications, and can improve the quality of life post-surgery compared to traditional open surgery. As detection methods improve and more lung cancers are diagnosed at an operable stage, the role of surgery in treatment regimens continues to expand.

How Are Technological Advances Transforming Lung Cancer Surgery?

The landscape of lung cancer surgery has been transformed by technological advancements that allow for more precise and less invasive procedures. Innovations such as robotic surgery provide surgeons with enhanced dexterity and control, enabling them to perform complex dissections and remove tumors with high precision while preserving healthy tissue. Furthermore, intraoperative imaging technologies like real-time CT scans and fluorescence imaging have improved the accuracy of tumor localization and the assessment of resection margins, ensuring that more of the cancerous tissue is removed during the initial surgery. These advancements not only increase the success rate of surgical interventions but also minimize the physical impact on patients, leading to faster recovery times and less postoperative discomfort.

What Impact Do Early Detection and Personalized Treatment Have on Lung Cancer Surgery Outcomes?

Early detection and personalized treatment approaches are significantly influencing outcomes in lung cancer surgery. The development of low-dose CT screening for high-risk individuals has led to earlier diagnosis of lung cancer, often at a stage when surgical resection is possible and more likely to be curative. Personalized medicine, which involves genetic profiling of tumors to understand their unique characteristics, has also made strides in determining which patients are good candidates for surgery and how they might best respond to additional treatments such as chemotherapy or targeted therapy. This tailored approach helps in strategizing treatment plans that maximize the efficacy of surgery and minimize unnecessary treatments, thereby improving overall patient survival and quality of life.

Growth in the Lung Cancer Surgery Market Is Driven by Several Factors

The growth in the lung cancer surgery market is driven by several factors, encompassing technological advancements, improved detection methods, and an increased emphasis on personalized medicine. Technological innovations in surgical techniques, including minimally invasive and robotic-assisted surgeries, have broadened the range of operable cases and improved patient outcomes, making surgery a more viable option for many patients. Enhanced screening programs have also played a critical role, as they increase the number of early-stage cancers identified, where surgical intervention can be most beneficial. Additionally, as understanding of the genetic basis of lung cancer improves, personalized surgical treatments are becoming more prevalent, allowing for more targeted and effective interventions. These developments, combined with a growing awareness of lung cancer risks and prevention, continue to drive the demand for surgical solutions in the treatment of lung cancer, reflecting a dynamic and evolving marketplace.

Select Competitors (Total 111 Featured) -

  • Abbott Molecular, Inc.
  • AbbVie, Inc.
  • Accuray, Inc.
  • Ackermann Instrumente GmbH
  • AngioDynamics, Inc.
  • Baxter International, Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Daiichi Sankyo Co., Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Lung Cancer Surgery - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Economic Update
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Lung Cancer Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Lung Cancer Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Lung Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Thoracotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Thoracotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Thoracotomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Surgical Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Surgical Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Surgical Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Monitoring & Visualizing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Monitoring & Visualizing Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Monitoring & Visualizing Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Lung Cancer Surgery Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Minimally Invasive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Minimally Invasive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Minimally Invasive Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Endosurgical Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Endosurgical Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Endosurgical Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • JAPAN
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • CHINA
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • EUROPE
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Lung Cancer Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Lung Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • FRANCE
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • GERMANY
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Lung Cancer Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Lung Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • INDIA
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: India 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Lung Cancer Surgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Lung Cancer Surgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Lung Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Lung Cancer Surgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Lung Cancer Surgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Lung Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030
  • AFRICA
    • Lung Cancer Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Lung Cancer Surgery by Procedure - Thoracotomy and Minimally Invasive Surgery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Lung Cancer Surgery by Procedure - Percentage Breakdown of Value Sales for Thoracotomy and Minimally Invasive Surgery for the Years 2014, 2024 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Lung Cancer Surgery by Device - Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Lung Cancer Surgery by Device - Percentage Breakdown of Value Sales for Surgical Instruments, Monitoring & Visualizing Systems and Endosurgical Equipment for the Years 2014, 2024 & 2030

IV. COMPETITION

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제